Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.69%18.74B | 14.82%64.11B | 13.64%15.66B | 11.21%55.83B | 8.94%13.93B | 4.08%13.46B | 20.53%14.66B | 11.87%13.78B | 36.05%50.2B | 12.79B |
| Cost of revenue | 24.62%11.85B | 14.82%40.32B | 9.74%9.51B | 9.28%35.11B | 7.52%8.63B | 2.56%8.51B | 17.86%9.32B | 9.55%8.66B | 29.33%32.13B | 8.02B |
| Gross profit | 12.06%6.9B | 14.81%23.79B | 20.27%6.15B | 14.65%20.72B | 11.33%5.31B | 6.79%4.95B | 25.49%5.35B | 16.03%5.12B | 49.89%18.08B | 4.77B |
| Operating expense | 39.18%3.51B | 17.82%11.76B | 4.86%2.52B | 4.23%9.98B | 6.15%2.62B | 5.19%2.55B | 1.40%2.4B | 4.07%2.41B | 22.25%9.58B | 2.47B |
| Staff costs | ---- | 16.54%4.65B | ---- | 7.20%3.99B | ---- | ---- | ---- | ---- | 25.49%3.72B | ---- |
| Selling and administrative expenses | ---- | 14.14%2.95B | ---- | 0.90%2.58B | ---- | ---- | ---- | ---- | 9.78%2.56B | ---- |
| -General and administrative expense | ---- | 14.14%2.95B | ---- | 0.90%2.58B | ---- | ---- | ---- | ---- | 9.78%2.56B | ---- |
| Depreciation and amortization | ---- | 12.00%252M | ---- | -0.44%225M | ---- | ---- | ---- | ---- | 13.57%226M | ---- |
| -Depreciation | ---- | 12.00%252M | ---- | -0.44%225M | ---- | ---- | ---- | ---- | 13.57%226M | ---- |
| Other operating expenses | ---- | 22.83%3.91B | ---- | 3.75%3.18B | ---- | ---- | ---- | ---- | 31.32%3.07B | ---- |
| Operating profit | -6.77%3.39B | 12.01%12.03B | 33.92%3.63B | 26.39%10.74B | 16.91%2.68B | 8.56%2.4B | 55.54%2.95B | 29.20%2.71B | 101.11%8.5B | 2.3B |
| Net non-operating interest income (expenses) | 552.63%124M | 108.02%13M | 132.76%19M | -18.25%-162M | 30.51%-41M | -8.33%-39M | 7.69%-24M | -262.50%-58M | -104.48%-137M | -59M |
| Non-operating interest income | 246.34%142M | 133.33%105M | 925.00%41M | 246.15%45M | 180.00%8M | 17.65%20M | 333.33%13M | 33.33%4M | 30.00%13M | ---10M |
| Non-operating interest expense | -18.18%18M | -43.56%92M | -64.52%22M | 8.67%163M | -89.80%5M | 11.32%59M | 27.59%37M | 226.32%62M | 94.81%150M | --49M |
| Total other finance cost | ---- | ---- | ---- | --44M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 129.29%174M | -250.57%-786M | -1,000.00%-594M | 54.44%522M | 8.36%350M | 472.00%286M | -37.40%-180M | -31.25%66M | 26.12%338M | 323M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 97.21%-29M | 0 | 0 | -309.84%-1.04B | 0 | |||||
| Income from associates and other participating interests | 0 | -100M | ||||||||
| Special income (charges) | -108.42%-16M | 4,081.25%1.34B | 19,100.00%190M | 288.24%32M | 1,100.00%40M | 18.75%-13M | 700.00%6M | -125.00%-1M | -102.60%-17M | -4M |
| Less:Restructuring and mergern&acquisition | ---- | ---1.15B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 108.42%16M | -500.00%-192M | -19,100.00%-190M | -288.24%-32M | -1,100.00%-40M | -18.75%13M | -700.00%-6M | 125.00%1M | 102.60%17M | --4M |
| Other non-operating income (expenses) | -69.31%31M | 208.57%324M | 3,266.67%101M | -6.25%105M | -55.07%31M | 44.90%71M | 0 | -66.67%3M | 165.12%112M | 69M |
| Income before tax | 10.58%3.7B | 15.26%12.92B | 22.87%3.35B | 46.54%11.21B | 21.56%3.06B | 122.20%2.7B | 57.96%2.72B | 24.27%2.72B | 64.40%7.65B | 2.52B |
| Income tax | 6.84%1.12B | 6.23%3.43B | 21.90%1.05B | 35.02%3.23B | -16.50%673M | 134.14%871M | 52.70%820M | 27.85%863M | 104.27%2.39B | 806M |
| Net income | 12.34%2.58B | 18.92%9.49B | 23.33%2.29B | 51.75%7.98B | 39.40%2.39B | 116.94%1.83B | 60.34%1.9B | 22.69%1.86B | 51.01%5.26B | 1.71B |
| Net income continuous operations | 12.29%2.58B | 18.91%9.49B | 23.32%2.3B | 51.77%7.98B | 39.49%2.39B | 116.94%1.83B | 60.34%1.9B | 22.68%1.86B | 51.01%5.26B | --1.71B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 12.34%2.58B | 18.92%9.49B | 23.33%2.29B | 51.75%7.98B | 39.40%2.39B | 116.94%1.83B | 60.34%1.9B | 22.69%1.86B | 51.01%5.26B | 1.71B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.34%2.58B | 18.92%9.49B | 23.33%2.29B | 51.75%7.98B | 39.40%2.39B | 116.94%1.83B | 60.34%1.9B | 22.69%1.86B | 51.01%5.26B | 1.71B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 25.42%38.43 | 9.93%139.93 | 0.00%30.64 | 50.23%127.29 | 26.98%35.56 | 114.31%29.8 | 66.66%31.29 | 27.43%30.64 | 53.41%84.73 | 28.005 |
| Diluted earnings per share | 40.55%38.37 | 19.32%139.7 | 0.00%27.3 | 54.72%117.08 | 40.36%35.075 | 116.77%26.825 | 66.05%27.88 | 26.89%27.3 | 53.18%75.67 | 24.99 |
| Dividend per share | 0 | 23.81%26 | 0 | 50.00%21 | 57.14%11 | 0 | 42.86%10 | 0 | 14 | 7 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |